Advanced Cardio - Lyvoo Module

What we test

Two biomarkers

That complete the cardiovascular assessment started in the base panel, focusing on genetic risk and cardiac function.

2 biomarkers Cardiovascular risk deepened beyond the base panel.

Lp(a)

Lipoprotein(a). Genetically determined cardiovascular risk factor, independent of LDL. Does not improve with statins.

NT-proBNP

Marker of cardiac stress and myocardial function. Elevated in subclinical cardiac dysfunction.

What this module is

Two markers the base panel doesn't include. And that change everything.

Lp(a) is genetically determined and represents a cardiovascular risk factor independent of LDL cholesterol - elevated levels do not improve with diet or statins. An estimated 20% of the population has clinically relevant levels without knowing it.

NT-proBNP evaluates mechanical stress on the myocardium, detecting early signs of subclinical cardiac dysfunction well before any symptoms appear.

Recommended for those with a family history of early cardiovascular disease or who have completed the base panel and want to deepen their cardiac assessment.

Who it's for

For those who want to go beyond cholesterol and blood pressure.

Family history of early heart disease or stroke
Controlled LDL cholesterol but persistent cardiovascular risk
Preventive assessment from age 40
Palpitations, unexplained fatigue or mild breathlessness
Complement to the base panel with cardiovascular analysis

Especially indicated for those with elevated Lp(a) in the family - a genetic risk that no healthy lifestyle can eliminate.

Planned contextualised report

Lp(a) and NT-proBNP contextualised with individual risk, family history and specific follow-up recommendations.

Timing confirmed before collection

Laboratory workflow and delivery timing will be confirmed before enrolment opens.